In December 2015, Clariant had announced plans to invest CHF 10 million in this Healthcare Packaging plant, that will support the growing generic pharmaceutical industry in India. The investment will be implemented through its wholly owned subsidiary in India.

“The new Healthcare Packaging manufacturing plant here in Cuddalore is another important step within our strategy to intensify growth and increase our market share in the emerging India region by rapidly addressing customer needs” said Christian Kohlpaintner, member of the Clariant Executive Committee.

The new plant will initially produce desiccant canisters and packets, which are inserted into pharmaceutical packaging to control moisture and protect the stability of the medicine during shelf life. The desiccant production area will be Clean Room Class 100,000 and certified ISO 8. It will be compliant with all relevant cGMP and US FDA standards.

With ten production sites in Gujarat, Maharashtra, Madhya Pradesh and Tamil Nadu and a state-of-the-art Regional Innovation Center in Mumbai, Clariant's new greenfield plant in Cuddalore will further reinforce its commitment to Make in India and Sell in India. The plant is slated for inauguration in 2017.

All rights reserved except agreement written by Emballage Digest or mention of the magazine